[Treatment of human papillomavirus infection of the uterine cervix with gel interferon].
Treatment of uterine cervix infection caused by human papillomavirus still is an enigma. Some drugs have been tested with cure rates between 60 to 70%. Most of such agents are substances which produce a strong epithelial desquamation and have shown strictly toxic side effects. The use of interferon in this infection has been studied, but different authors disagree in their therapeutic findings. A randomized, double blind trial was conducted to compare interferon to placebo. Preliminary results are presented in this article. 47 patients were followed so far. 18 of them were evaluated and the results are shown in this article.
das Dôres
G B
GB
Escola Paulista de Medicina, São Paulo, SP.
Ribalta
J C
JC
Martins
N V
NV
Focchi
J
J
Novo
N F
NF
Kosmiskas
J B
JB
De Lima
G R
GR
D003218:Condylomata Acuminata / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000628:therapy*; D014622:Vaginal Creams, Foams, and Jellies
D014622:Vaginal Creams, Foams, and Jellies; D007372:Interferons
Tratamento da infecção do colo uterino por papilomavírus humano com interferon gel.